Skip to main content

Press Releases

Browse current and past press releases from The Michael J. Fox Foundation.

From
To
  • Default content image

    The Michael J. Fox Foundation Expands Fox Trial Finder to Accelerate Research in Atypical Parkinsonism

    Atypical parkinsonisms, rare conditions that affect a significant number of individuals, are often misdiagnosed as Parkinson's Expansion of Fox Trial Finder aims to increase engagement in atypical…
    Learn more

  • Default content image

    Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson's Trust Collaborate to Assess the Clinical Use and Development of Nilotinib in Parkinson's Disease

    Investigators will focus on safety for long-term use in non-cancer patients Partners aim to design and co-fund a multi-site trial to begin in 2017; trial endpoints would include precise biological…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Announces $2M Prize for First PET Tracer to Visualize Key Parkinson's Protein in Living Brain

    Tracer to visualize alpha-synuclein protein would aid in Parkinson's diagnosis, progression tracking and testing of novel therapies MJFF will award a $2 million alpha-synuclein imaging prize to the…
    Learn more

  • Default content image

    The Michael J. Fox Foundation Announces $25,000 Data Challenge to Advance Parkinson’s Understanding and Study Design

    Foundation Calls Computational Analysts to Develop Quantitative Models from Parkinson’s Progression Markers Initiative Dataset Answering Fundamental Questions on Parkinson’s Progression and Sub…
    Learn more

  • Default content image

    Georgetown University and The Michael J. Fox Foundation for Parkinson’s Research Offer Fellowship in Regulatory Science

    WASHINGTON and NEW YORK — Georgetown University Medical Center and The Michael J. Fox Foundation for Parkinson’s Research announce a fellowship in regulatory science that will promote…
    Learn more

  • Default content image

    Michael J. Fox Foundation Supports Two Engineered Stem Cell Research Projects for Parkinson’s Therapeutic Development and Disease Investigation

    Harvard Teaching Hospitals funded to develop dopamine neuron replacement treatment Parkinson’s Progression Markers Initiative making iPSCs available to broad research community Dopamine neurons…
    Learn more

  • Default content image

    National Stem Cell Foundation and Michael J. Fox Foundation Partner to Support Parkinson’s Cell Replacement Therapy

    LOUISVILLE and NEW YORK -- The National Stem Cell Foundation (NSCF) and The Michael J. Fox Foundation for Parkinson's Research (MJFF) have announced a partnership to fund development of a cutting…
    Learn more

We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.